pM-Gal4-HIF-1a vector
Invented at Drexel University
- Datasheet
- References (4)
- Inventor Info
Info
| Catalogue Number | 154130 |
| Backbone Size (bp) | 3500 |
| Bacterial Resistance | Ampicillin |
| Selectable Markers | Ampicillin, G418 |
| Vector Type | pM |
| Antigen/Gene or Protein Targets | HIF-1a (Truncated) and GAL4 (DNA binding domain) |
| Relevance | This plasmid is useful for testing the the transactivation activity of HIF-1a |
| Research Area | Epigenetics & Nuclear Signalling, Metabolism |
References: 4 entries
Sang et al. 2003. J Biol Chem. 278(16):14013-9. PMID: 12588875.
MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300.
Europe PMC ID: 12588875
Sang et al. 2002. Mol Cell Biol. 22(9):2984-92. PMID: 11940656.
Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP.
Europe PMC ID: 11940656
Add a reference
References: 4 entries
Sang et al. 2003. J Biol Chem. 278(16):14013-9. PMID: 12588875.
MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300.
Sang et al. 2002. Mol Cell Biol. 22(9):2984-92. PMID: 11940656.
Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP.
Add a reference
